Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ifosfamide encephalopathy.

T Ajithkumar1, C Parkinson, F Shamshad

  • 1Department of Oncology, Addenbrooke's Oncology Centre, Hills Road, Cambridge CB2 2QQ, UK. tvajith@hotmail.com

Clinical Oncology (Royal College of Radiologists (Great Britain))
|March 16, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Yarning about vaccinations: Empowering individuals to have supportive conversations with Aboriginal peoples about vaccinations, using a community-engaged approach.

Australian and New Zealand journal of public health·2025
Same author

High speed single pixel imaging using a microLED-on-CMOS light projector.

Optics express·2024
Same author

Search for Leptonic Decays of Dark Photons at NA62.

Physical review letters·2024
Same author

The Evolving Role of Novel Imaging Techniques for Radiotherapy Planning.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

The Benefits of a Rapid Access Pathway for Patients Requiring Single Fraction Radiotherapy Treatment: The Cambridge Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2024
Same author

Development and psychometric validation of the gum health experience questionnaire.

Journal of clinical periodontology·2023
Same journal

Research Trends in Physical Activity and Breast Cancer: A 25-Year Bibliometric Analysis (2000-2025).

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Concordance Between Planned and Delivered treatment for Head and Neck Cancer Patients Treated With Curative Intent: A Real-World Comparison of Under 70-year-olds With 70-year-olds and Over.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

A Novel Technique for Pain Management to Deliver a Course of Palliative Radiotherapy.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Broad-Spectrum Antibiotics are Associated with worse Survival After Radical Treatment for Glioblastoma Multiforme: A Multicentre Study.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Exploring the Need for Plan Adaptation in Robustly Optimised Head and Neck Intensity Modulated Proton Therapy: A Dosimetric Perspective From Initial Institutional Experience.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
Same journal

Lifting the Lid on Best Practice in a Case of Oligometastatic Breast Cancer.

Clinical oncology (Royal College of Radiologists (Great Britain))·2026
See all related articles

Ifosfamide causes potentially fatal encephalopathy, ranging from confusion to coma. Early detection and stopping ifosfamide are crucial, with methylene blue showing promise for prevention and treatment.

Area of Science:

  • Neuroscience
  • Oncology
  • Pharmacology

Background:

  • Ifosfamide is an alkylating agent used in chemotherapy.
  • Ifosfamide-induced encephalopathy is a serious, potentially fatal neurotoxicity.
  • Clinical symptoms range from mild confusion to severe coma.

Purpose of the Study:

  • To review the current understanding of ifosfamide-induced encephalopathy.
  • To discuss the management and prediction of this toxicity.
  • To explore the potential role of methylene blue in mitigating neurotoxicity.

Main Methods:

  • Literature review of ifosfamide encephalopathy.
  • Analysis of clinical manifestations and management strategies.
  • Examination of evidence for methylene blue in neurotoxicity.

Related Experiment Videos

Main Results:

  • Ifosfamide encephalopathy presents with diverse neurological symptoms.
  • Early identification and drug cessation are key management principles.
  • Methylene blue is investigated for its potential prophylactic and therapeutic effects.

Conclusions:

  • Ifosfamide encephalopathy requires prompt recognition and intervention.
  • Accurate prediction of this toxicity remains challenging.
  • Methylene blue may offer a novel approach to prevent and treat ifosfamide neurotoxicity.